GelStat Corporation (GSAC)

OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Mar 4, 2026
0.00%
Market Cap 1.12M
Revenue (ttm) 363.53K
Net Income (ttm) -283.40K
Shares Out 3.74B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 151,666
Average Volume 2,018,189
Open 0.0003
Previous Close 0.0003
Day's Range 0.0003 - 0.0003
52-Week Range 0.0002 - 0.0005
Beta 1.26
RSI 45.27
Earnings Date Sep 26, 2025

About GelStat

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialt... [Read more]

Sector Technology
Founded 2002
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol GSAC
Full Company Profile

Financial Performance

In 2024, GelStat's revenue was $349,730, an increase of 133.89% compared to the previous year's $149,527. Losses were -$372,947, 77.5% more than in 2023.

Financial Statements

News

There is no news available yet.